India to United States: Cyclophosphamide Export Trade Route
India has recorded 170 verified shipments of Cyclophosphamide exported to United States, representing a combined trade value of $14.8M USD. This corridor is served by 16 active Indian exporters, with an average shipment value of $87.3K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 55% of total export value with 7 shipments worth $8.2M USD. On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer in United States with $8.1M USD in purchases. The top 3 suppliers — CIPLA LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, ALEMBIC PHARMACEUTICALS LIMITED — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Cyclophosphamide corridor is one of India's established pharmaceutical export routes, with 170 shipments documented worth a combined $14.8M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's cyclophosphamide manufacturing sector.
Across 16 active suppliers, the average shipment value stands at $87.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with cyclophosphamide's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 13.1%, placing it at rank #6 among India's top cyclophosphamide export destinations globally.
On the import side, key buyers of Indian cyclophosphamide in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, EUGIA US LLC, EUGIA US LLC, and 36 others. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the single largest importer with 6 shipments valued at $8.1M USD.
Route Characteristics
- Average transit23 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#6
- Annual growth+13.1%
- Demand growth+13.4%
- Regulatory ease81/100
Top 10 Indian Cyclophosphamide Exporters to United States
Showing top 10 of 16 Indian suppliers exporting Cyclophosphamide to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $1.2M per shipment | 7 | $8.2M | 55.2% |
| 2 | EUGIA PHARMA SPECIALITIES LIMITED Avg $279.4K per shipment | 19 | $5.3M | 35.8% |
| 3 | ALEMBIC PHARMACEUTICALS LIMITED Avg $30.8K per shipment | 27 | $830.4K | 5.6% |
| 4 | DR REDDYS LABORATORIES LIMITED Avg $244.3K per shipment | 1 | $244.3K | 1.6% |
| 5 | EPSILON PHARMACEUTICALS PRIVATE LIMITED Avg $90.7K per shipment | 2 | $181.3K | 1.2% |
| 6 | ALEMBIC PHARMACEUTICALS LTD Avg $19.2K per shipment | 2 | $38.5K | 0.3% |
| 7 | ATLAS ENTERPRISES Avg $374 per shipment | 64 | $24.0K | 0.2% |
| 8 | KOIT BIOPHARMA PRIVATE LIMITED Avg $615 per shipment | 24 | $14.8K | 0.1% |
| 9 | VINAYAK ASSOCIATES Avg $2.0K per shipment | 5 | $10.0K | 0.1% |
| 10 | GLOBYZ BIOPHARMA PRIVATE LIMITED Avg $99 per shipment | 8 | $794 | 0.0% |
This table shows the top 10 of 16 Indian companies exporting cyclophosphamide to United States, ranked by total trade value. The listed exporters are: CIPLA LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, DR REDDYS LABORATORIES LIMITED, EPSILON PHARMACEUTICALS PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LTD, ATLAS ENTERPRISES, KOIT BIOPHARMA PRIVATE LIMITED, VINAYAK ASSOCIATES, GLOBYZ BIOPHARMA PRIVATE LIMITED. CIPLA LIMITED is the dominant supplier with 7 shipments worth $8.2M USD, giving it a 55% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Showing top 10 of 16 total Indian exporters on the India to United States Cyclophosphamide export route.
Top 10 Cyclophosphamide Importers in United States
Showing top 10 of 39 known buyers in United States receiving Cyclophosphamide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian cyclophosphamide in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, EUGIA US LLC, EUGIA US LLC,, J. KNIPPER & COMPANY, DR REDDYS LABORATORIES INC, among 39 total buyers. The largest importer is CIPLA USA INC UPS SUPPLY CHAIN SOLU, accounting for $8.1M USD across 6 shipments — representing 55% of all cyclophosphamide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 6 | $8.1M | 54.6% |
| 2 | EUGIA US LLC | 11 | $3.4M | 23.1% |
| 3 | EUGIA US LLC, | 8 | $1.9M | 12.6% |
| 4 | J. KNIPPER & COMPANY | 14 | $467.5K | 3.1% |
| 5 | DR REDDYS LABORATORIES INC | 1 | $244.3K | 1.6% |
| 6 | J KNIPPER COMPANY | 4 | $185.6K | 1.3% |
| 7 | XXNEAXXEU XXMITXX | 2 | $181.3K | 1.2% |
| 8 | J. KNIPPER & COMPANY, | 9 | $152.4K | 1.0% |
| 9 | CIPLA USA INC UPS SUPPLY CHAIN SOL | 1 | $78.0K | 0.5% |
| 10 | J.KNIPPER & COMPANY | 2 | $63.4K | 0.4% |
Showing top 10 of 39 Cyclophosphamide importers in United States on this route.
Top 10 Cyclophosphamide Formulations Imported by United States
Showing top 10 of 91 product formulations shipped on the India to United States Cyclophosphamide route, ranked by trade value
United States imports a wide range of cyclophosphamide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CYCLOPHOSPHAMIDE CAPS 50MG NDC NO.69097-517-07ANDA NO.211608 (INV.QTY.1632 PACK 1 X 100S =163200 NOS) — accounts for $7.8M USD across 1 shipments. There are 91 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CYCLOPHOSPHAMIDE CAPS 50MG NDC NO.69097-517-07ANDA NO.211608 (INV.QTY.1632 PACK 1 X 100S =163200 NOS) | 1 | $7.8M | 52.7% |
| 2 | CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML 1000 MG/5ML7438X1'S | 1 | $731.2K | 4.9% |
| 3 | CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML (500 MG/2.5 ML),(7677X1'S) | 1 | $449.4K | 3.0% |
| 4 | CYCLOPHOSPHAMIDE INJECTION 200MG/ML (CYCLOPHOSPHAMIDE INJECTION CONCENTRATE, 200MG/ML (1000MG/5ML) (MDV)-US (ST)) (6960x | 1 | $444.4K | 3.0% |
| 5 | CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML 500 MG/2.5 ML7476X1'S | 1 | $440.0K | 3.0% |
| 6 | CYCLOPHOSPHAMIDE INJECTION CONCENTRATE,200MG/ML (2000MG/10ML) (MDV)-US (ST) (2860 x 1's PACK) | 1 | $434.3K | 2.9% |
| 7 | CYCLOPHOSPHAMIDE INJECTION CONCENTRATE,200MG/ML (2000MG/10ML) (MDV)-US (ST) (2640X1'S PACK) | 1 | $396.5K | 2.7% |
| 8 | CYCLOPHOSPHAMIDE INJECTION CONCENTRATE,200MG/ML (2000MG/10ML) (MDV)-US (ST) (2200 X 1'S PACK) | 1 | $326.3K | 2.2% |
| 9 | CYCLOPHOSPHAMIDE INJECTION 200MG/ML (CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200MG/ML (2000 MG/10 ML),(1885X1'S) | 1 | $280.7K | 1.9% |
| 10 | CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML (1000 MG/5ML),(1890X1'S) | 1 | $267.3K | 1.8% |
Showing top 10 of 91 Cyclophosphamide formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 68 shipments. Transit time averages 23 days by sea.
Market Dynamics
India's cyclophosphamide exports to United States are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 16 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, ALEMBIC PHARMACEUTICALS LIMITED — together account for 97% of total trade value on this route. The average shipment value of $87.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as cyclophosphamide injection concentrate 200 mg/ml 1000 mg/5ml7438x1's and cyclophosphamide injection concentrate 200 mg/ml (500 mg/2.5 ml),(7677x1's), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer with 6 shipments worth $8.1M USD — representing 55% of all cyclophosphamide imports from India on this route. A total of 39 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $14.8M
- Avg. Shipment
- $87.3K
- Suppliers
- 16
- Buyers
- 39
- Transit (Sea)
- ~23 days
- Annual Growth
- +13.1%
Related Analysis
Reverse Direction
United States → India — Cyclophosphamide (Import)Other Cyclophosphamide Routes
Unlock the Full India to United States Cyclophosphamide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 170 shipments on this route.
Frequently Asked Questions — India to United States Cyclophosphamide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Cyclophosphamide to United States?
The leading Indian exporters of Cyclophosphamide to United States are CIPLA LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, ALEMBIC PHARMACEUTICALS LIMITED. CIPLA LIMITED holds the largest market share at approximately 55% of total trade value on this route.
Q What is the total value of Cyclophosphamide exports from India to United States?
India exports Cyclophosphamide to United States worth approximately $14.8M USD across 170 recorded shipments. The average value per shipment is $87.3K USD.
Q Which ports does India use to ship Cyclophosphamide to United States?
The most active port of origin is SAHAR AIR with 68 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to United States for Cyclophosphamide?
The average transit time for Cyclophosphamide shipments from India to United States is approximately 23 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Cyclophosphamide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.1% with demand growth tracking at 13.4%. The route is ranked #6 among India's top Cyclophosphamide export destinations globally.
Q How many suppliers are active on the India to United States Cyclophosphamide route?
There are currently 16 active Indian suppliers exporting Cyclophosphamide to United States. The market is moderately concentrated with CIPLA LIMITED accounting for 55% of total shipment value.
Q Who are the main importers of Cyclophosphamide from India in United States?
The leading importers of Indian Cyclophosphamide in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, EUGIA US LLC, EUGIA US LLC,, J. KNIPPER & COMPANY, DR REDDYS LABORATORIES INC. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer with 6 shipments worth $8.1M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Cyclophosphamide.
- 2.Supplier/Buyer Matching: 16 Indian exporters and 39 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 170 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
170 Verified Shipments
16 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists